# Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients.

> **NCT00593125** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 15 (actual)

## Conditions studied

- Cocaine Dependence
- Opioid Dependence

## Interventions

- **DRUG:** levetiracetam

## Key facts

- **NCT ID:** NCT00593125
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-08
- **Final completion:** 2008-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00593125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00593125, "Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00593125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*